The PERKAT™ device can be implanted percutaneously with no need for surgical intervention therefore saving the patient additional strain. After an operating period between a few hours and 10 days maximum explantation of PERKAT™ is also performed percutaneously. The complete procedure is safe and efficient for the patient as well as for the implementing cardiologist.
Additional to the provided high heart support of more than 3 L/min there are further advantages such as the reduced risk of infection and haemolysis for the patient with PERKAT™. The pump volume can be also controlled by ECG-triggering.
The PERKAT™ right ventricular heart pump is technically a completely new approach to heart assist devices thus enabling percutaneous, pulsatile and self-expanding working principles in one device.
Using the PERKAT™ technology we plan to realise a biventricular version of PERKAT™
in which all advantages of PERKAT™ RV are transferred to a biventricular heart pump in the future.
The products are not available yet in the market, because they are still in the development.